ICMR starts BCG vaccine trials on elderly. Here is why
ICMR has started a trial to evaluate the effectiveness of the 80-year-old BCG vaccine in reducing morbidity and mortality in elderly individuals in Covid-19 hotspots in India. ET’s Divya Rajagopal gives you the details. Watch
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
- Category
- HOW TO
Comments